Danaher-Masimo close caps med tech’s strongest first-half since 2022
· amanda lanier
AI Briefing
- • Med-tech M&As reached $75.73 billion in collective value through H1 2026.
- • This is the highest H1 total since 2022's $120.4 billion in Med-tech M&As.
- • June contributed $12.21 billion, rebounding from May's $1.51 billion.
Source Summary
Med-tech M&As through the first half (H1) of 2026 reached $75.73 billion in collective value, the highest H1 total since 2022’s $120.4 billion and well above every other year in BioWorld’s records. June contributed $12.21 billion, a rebound from May’s relatively quiet $1.51 billion.
Advertisement